Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × cabazitaxel × Clear all

Sponsor

Conditions

Prostatic Neoplasms 15 Prostate Cancer Metastatic 3 Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Carcinoma, Transitional Cell 2 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Metastatic Breast Cancer With Intracranial Metastases 1 Malignant Solid Tumor - Malignant Nervous System Neoplasm 1 Hormone-Resistant Prostate Cancer 1 Esophageal Neoplasms 1

Interventions

Gemcitabine 11 Cisplatin 11 Capecitabine 11 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 8 pembrolizumab 7 Paclitaxel 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Pemetrexed 4 Nivolumab 4 Irinotecan 4 Everolimus 4 Erlotinib Hydrochloride 4 Docetaxel 4 Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2 vosaroxin 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡